June 5 (Reuters) - Tempus AI is targeting a valuation of

up to $6.10 billion in its initial public offering in the United

States, the genetics testing company said on Wednesday.

The company has incurred significant losses since its

inception and is yet to achieve profitability, which will test

investor appetite for an IPO.

Tempus, led by e-commerce marketplace Groupon ( GRPN )

co-founder Eric Lefkofsky, is aiming to raise as much as $410.7

million by selling 11.1 million shares at a price range of $35

to $37 each.

It will list on the Nasdaq Global Select Market under the

symbol "TEM".

Morgan Stanley, J.P. Morgan Securities and Allen & Company

are the lead underwriters for the offering.